P. Gontero Et Al. , "Making a case “against” focal therapy for intermediate-risk prostate cancer," World Journal of Urology , vol.39, no.3, pp.719-728, 2021
Gontero, P. Et Al. 2021. Making a case “against” focal therapy for intermediate-risk prostate cancer. World Journal of Urology , vol.39, no.3 , 719-728.
Gontero, P., Marra, G., Teber, D., Shariat, S., ALBAYRAK, S., Coelho, R., ... Tanguay, S.(2021). Making a case “against” focal therapy for intermediate-risk prostate cancer. World Journal of Urology , vol.39, no.3, 719-728.
Gontero, Paolo Et Al. "Making a case “against” focal therapy for intermediate-risk prostate cancer," World Journal of Urology , vol.39, no.3, 719-728, 2021
Gontero, Paolo Et Al. "Making a case “against” focal therapy for intermediate-risk prostate cancer." World Journal of Urology , vol.39, no.3, pp.719-728, 2021
Gontero, P. Et Al. (2021) . "Making a case “against” focal therapy for intermediate-risk prostate cancer." World Journal of Urology , vol.39, no.3, pp.719-728.
@article{article, author={Paolo Gontero Et Al. }, title={Making a case “against” focal therapy for intermediate-risk prostate cancer}, journal={World Journal of Urology}, year=2021, pages={719-728} }